Stay updated on scAAV9.U1a.hSGSH Gene Transfer Clinical Trial
Sign up to get notified when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.

Latest updates to the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to reflect the latest details of the Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA, including new dates and specific criteria for patient enrollment. Notably, the trial's objective has been clarified, and the list of collaborators has been updated.SummaryDifference41%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 19, 2025.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect the latest version, v2.14.3, with a new last update date of March 25, 2025, replacing the previous version v2.14.2 and its update date of February 19, 2025.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has updated the details of a clinical trial for UX111, including the timeline for the administration of prophylactic immunomodulatory therapy, and has changed the contact email for a key individual involved in the trial.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to scAAV9.U1a.hSGSH Gene Transfer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.